The event occurs on 16 May 2023 under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project.
This webinar is dedicated to supporting potential beneficiaries to participate in the open 2023 calls for the mission “Soil Health and Food” that takes online on 16th May 2023 at 10:00 am.
TRANSCAN-3 is a European research funding initiative focused on translational cancer research. It aims to promote international collaboration among researchers and institutions in the field of cancer research. TRANSCAN-3 organizes Joint Transnational Calls (JTC) to fund collaborative research projects addressing specific topics related to cancer. The specific aims and objectives of a b2match event related to TRANSCAN-3 JTC2023 would depend on the organizers and the goals they set for the event. However, in general, such an event could have the following aims and objectives:
- Facilitate Collaboration: The event could bring together researchers, scientists, clinicians, and industry professionals from different countries and disciplines to foster collaboration and knowledge exchange in the field of translational cancer research.
- Project Development: The event could provide a platform for researchers to discuss project ideas, form consortia, and develop research proposals for the TRANSCAN-3 JTC2023. It could facilitate networking opportunities and enable potential project partners to connect and explore collaborative opportunities.
- Knowledge Sharing: The event could feature presentations, workshops, and panel discussions on relevant topics in translational cancer research, allowing participants to share their expertise, present their work, and learn from each other's experiences.
- Funding Information: The event could provide information and guidance on the TRANSCAN-3 JTC2023 funding program, including the application process, eligibility criteria, and evaluation procedures. This would help participants understand the requirements and increase their chances of successfully applying for funding.
Recording:
Comments
0 comments
Article is closed for comments.